|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue, net | |||||
| Operating expenses: | |||||
| Cost of revenue (exclusive of items shown separately below) | |||||
| Research and development | |||||
| General and administrative | |||||
| Sales and marketing | |||||
| Intangible amortization expense | |||||
| Asset write-down and restructuring | |||||
| Goodwill impairment | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income, net | |||||
| Gain on warrant liability | |||||
| Gain (loss) on warrant liabilities | |||||
| Other income, net | |||||
| Income (loss) before income tax expense | |||||
| Income tax benefit (expense) | |||||
| Net income (loss) | |||||
| Net income (loss) per share | |||||
| Basic net income (loss) per share | |||||
| Diluted net income (loss) per share | |||||
| Weighted-average shares used in computing net income (loss) per share | |||||
| Weighted average shares outstanding, Basic | |||||
| Weighted average shares outstanding, Diluted | |||||
Loading...